Business Wire

CORRECTING and REPLACING Connected Objects: a Global Ambition at Total

Share

Please replace the release dated July 10, 2018 with the following corrected version due to multiple revisions.

The corrected release reads:

CONNECTED OBJECTS: A GLOBAL AMBITION AT TOTAL

Total has joined forces with Sigfox, the world’s leading IoT connectivity service, to deploy a solution designed to optimise rolling stock and help manage trailer fleets.

What’s the solution?

Created by transporters, for transporters, Where’s my Trailer? is an innovative new way to improve how trailer fleets are used and kept secure.

The solution works by installing a box on the trailer, to identify any equipment that is underused or has been lost or stolen.

Our partnership

The solution was developed by Total Marketing France through its subsidiary Stela and has been in test phase for a year with the company’s transporter customers.

“Sigfox technology, together with our proximity to Freight and Logistics, has given us the opportunity to offer a reliable and efficient way of geolocalising rolling stock throughout Europe,” explains Benoît Luc, Director of Total’s European Marketing & Services Department.

“We are delighted with how the Total project has developed,” adds Patrick Cason, Managing Director of Sigfox France. “The significant size of the Total group has in no way hindered our progress, in fact quite the opposite. We have seen how its full force can really benefit innovation. The group knows how to listen to its customers, how to think about their experience as users, and how to commit to providing innovative services. Our teams worked together very easily because Total both responds and makes decisions promptly.”

How it works

The boxes are self-powered and very easy to install on the trailer. They communicate using Sigfox technology, which is able to provide a low bandwidth connection network at a very low cost.

Where’s my Trailer? localises any stationery trailers and allows users to set up notifications. Messages are displayed on the secure customer portal, which can be accessed from the websites stela.fr and as24.com,and are compatible with all digital devices.

Maps and dashboards provide information on:

  • Trailers and a track record of inactive periods
  • Tractor-trailer pairing – drop-and-hook detection
  • Maintenance – vehicle safety inspection, repairs
  • Unauthorised movement during time periods can be configured by the customer

How to access the service

Where’s My Trailer? is easy to deploy and use, and is very competitively priced on the transport market.

This solution marks the end of high costs and complex systems: benefiting from Sigfox’s services and international network, this disruptive solution both significantly reduces costs and simplifies the system’s implementation, unlike current solutions that are complex to deploy.

It will be available from July 9, 2018, first in France and then in Europe, through Stela and AS24. There will also be a hotline open 5 days a week, to help customers install their boxes, use the secure portal, and configure their options. Where’s my Trailer? is free to download – the only requirement is to purchase a subscription.

The solution is scalable and will soon include new features.

Please note

This press release is for informational purposes only and shall have no legal consequences. The entities in which TOTAL SA directly or indirectly owns a stake are separate and autonomous. TOTAL SA shall not be held liable for the actions or omissions of the aforementioned companies. The terms “TOTAL”, “TOTAL Group” and “Group” as presented in this document are generic and used for convenience only. Similarly, the terms “we”, “us” and “our” may also be used to refer to subsidiaries or employees of those subsidiaries.

This document may contain forward-looking information and statements that are based on economic data and assumptions made based on a particular economic, competitive and regulatory context. They may prove inaccurate in the future and are dependent on risk factors. Neither TOTAL SA nor any of its affiliates make any commitment or take on any responsibility in relation to investors or any other party to update or revise any or all statements, forward-looking information, trends or objectives contained in this document, especially as a result of new information or future events.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Sigfox
Eleanor Burgess +44 (0)7773931979
or
Sales relations:
ingrid.aeck@stela.fr

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 02:09:00 CEST | Press release

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines,today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio har

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 22:06:00 CEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

HiddenA line styled icon from Orion Icon Library.Eye